ATAGI COVID Working Group
Subgroup 3, Meeting No. 21
10 June 2021, 11:30 – 12:30pm
In attendance:
Members
NCIRS Technical Staff
Department of Health reps
Nigel Crawford - lead
s 47F
s 22
Tony Korman
Darius Everett
John Kaldor
s 22
Paul Effler
Leanne Ringwood
Katie Attwell
s 22
Chris Blyth
Debra Petrys
Kristy Cooper
Secretariat
Margie Danchin
Invited Representatives
s 22
Cheryl Jones
s 47F
Kristine Macartney
1. Welcome and apologies / general committee business
Members:
NOTED acknowledgement to country
NOTED attendees and apologies (Catherine King, Christine Selvey, Alan Leeb)
s 47F
ACT 1982 (CTH)
Declared no conflicts of interest.
2. Outcomes from previous meeting
Members ENDORSED outcomes and actions from previous me
HEALTH eting with no amendments.
3. TTS information for primary care
INFORMATION
Members NOTED and DISCUSSED:
How ATAGI can provide guidance in identification, referral and management of suspected
TTS cases after AstraZeneca COVID-19 vaccine in primary care (GP, Emergency)
Importance of patient and healthcare provider awareness of TTS symptoms
Emergency waiting times and how su
FREEDOM OF spected TTS cases can be flagged and escalated quickly
Cues to support nurses who are not immunisers (e.g. AstraZeneca vac
THIS DOCUMENT HAS BEEN RELEASED UNDER cine as screening
question)
THE
Jurisdictions are collecting TTS mortality and mor
BY THE DEPARTMENT OF bidity information
Importance of including full TTS cases in risk-benefit document, as estimated rates/ratio may
be difficult for the public to interpret
o Risk-benefit document is currently being updated.
Action
Responsible officer/s
Progress
3.1 Draft 1-2 pager guidance on TTS
NCIRS/SG3
To progress
management in primary care
Draft guidance for ACEM review
RACGP to disseminate to members
4. TGA update
Nil.
Document 21
Page 1 of 2
FOI 2917
ATAGI COVID Working Group
Subgroup 3, Meeting No. 21
10 June 2021, 11:30 – 12:30pm
s 22
UNDER
(CTH)
1982
ACT
RELEASED
BEEN HEALTH
HAS INFORMATION
OF
OF
DOCUMENT
FREEDOM
DEPARTMENT
THIS
THE THE
BY
Meeting closed at 12:35pm.
Document 21
Page 2 of 2
FOI 2917
